Growth Metrics

Omeros (OMER) Short term Debt (2011 - 2025)

Omeros recorded quarterly Short term Debt of $17.1 million in Q4 2025, down 36.64% quarter-over-quarter from $26.9 million in Q1 2025, and down 18.75% year-over-year from $21.0 million in Q4 2024.

Omeros' Short term Debt history runs 12 years deep, the most recent figure standing at $17.1 million for Q4 2025.

  • In Q4 2025, Short term Debt fell 18.75% year-over-year to $17.1 million; the TTM figure through Dec 2025 stood at $17.1 million (down 18.75% YoY), while the FY2025 annual figure was $17.1 million, down 18.75% from the prior year.
  • Short term Debt came in at $17.1 million for Q4 2025 at Omeros, down from $26.9 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $94.9 million in Q3 2023 to a low of $17.1 million in Q4 2025.
  • A 4-year average of $63.4 million and a median of $94.4 million in 2022 frame the typical range for Short term Debt.
  • On a YoY basis, Short term Debt climbed as much as 18.75% in 2025 and fell as far as 18.75% in 2025.
  • Omeros' Short term Debt stood at $94.4 million in 2022, then rose by 0.56% to $94.9 million in 2023, then sank by 77.87% to $21.0 million in 2024, then decreased by 18.75% to $17.1 million in 2025.
  • According to Business Quant data, Short term Debt over the past three periods registered $17.1 million, $26.9 million, and $21.0 million for Q4 2025, Q1 2025, and Q4 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Omeros 772.03 Mn 636.71 Mn 9.31 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 17.06 Mn
Mar 31, 2025 26.93 Mn
Dec 31, 2024 21.00 Mn
Sep 30, 2023 94.91 Mn
Jun 30, 2023 94.73 Mn
Mar 31, 2023 94.55 Mn
Dec 31, 2022 94.38 Mn
Mar 31, 2019 2.56 Mn
Dec 31, 2018 889,000.00
Sep 30, 2018 560,000.00
Jun 30, 2018 608,000.00
Mar 31, 2018 513,000.00
Dec 31, 2017 490,000.00
Sep 30, 2017 368,000.00
Jun 30, 2017 250,000.00
Mar 31, 2017 228,000.00
Dec 31, 2016 198,000.00
Sep 30, 2016 190,000.00
Jun 30, 2016 193,000.00
Mar 31, 2016 69,000.00
Dec 31, 2015 73,000.00
Sep 30, 2015 9.58 Mn
Jun 30, 2015 9.29 Mn
Mar 31, 2015 9.02 Mn
Dec 31, 2014 6.33 Mn
Sep 30, 2014 3.99 Mn
Jun 30, 2014 1.61 Mn
Dec 31, 2013 5.60 Mn
Sep 30, 2013 4.02 Mn
Jun 30, 2013 2.49 Mn
Mar 31, 2013 997,000.00
Dec 31, 2011 5.90 Mn